Antibiotiques

<p>Amicoumacin C is a biological product derived from certain strains of the Bacillus species, specifically fermented by Bacillus subtilis. It is recognized as a potent antibiotic compound, noted for its ability to inhibit bacterial protein synthesis, primarily by interacting with the 30S ribosomal subunit, thereby hindering the translation process.</p>

Sinefungin (Adenosyl-Ornithine) is an effective inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral

Erythromycin and its derivatives; salts thereof

<p>Nortopixantrone(BBR 3438) is a novel 9-azacyclophenanthracene pyrazole that shows antitumor activity in a human prostate cancer model.</p>

Erythromycylamine is a useful organic compound for research related to life sciences. The catalog number is T64443 and the CAS number is 26116-56-3.

Formycin A shows antitumor and antiviral activities. Formycin A , a purine nucleoside antibiotic, is a potent human immunodeficiency virus type 1 (HIV-1) inhibitor with an EC50 of 10 μM.

<p>A 53868A is an antibiotic, it is isolated from Streptomyces luridus.</p>

Swainsonine (Tridolgosir) is an alkaloid isolated from Astragalus membranaceus and is a potent and reversible inhibitor of alpha-mannosidase. swainsonine has antitumour activity and induces apoptosis and cell cycle arrest in the G2/M phase.

<p>Cefsulodin sodium salt is a beta lactam antibiotic in the third-generation cephalosporin family that inhibits penicillin-binding proteins (PBPs) to disrupt bacterial cell wall synthesis.</p>

<p>Amicoumacin A is an antibiotic compound, which is derived from the bacterium Bacillus subtilis. This natural source is known for its production of a variety of biologically active compounds that contribute to its utility in numerous scientific contexts. The mode of action of Amicoumacin A involves the inhibition of bacterial protein synthesis by targeting the ribosomal subunit. Specifically, it interferes with the translation process, effectively disrupting the growth and proliferation of susceptible bacterial strains.<br><br>Amicoumacin A is primarily utilized in research settings to study bacterial resistance mechanisms, as well as to explore novel antibacterial therapies. Its application in scientific research extends to examining its potential synergistic effects with other antimicrobial agents, and it serves as a model compound for understanding ribosomal inhibition. The study of Amicoumacin A not only contributes to the broader field of antibiotic development but also offers insights into the molecular interactions that underlie bacterial protein synthesis and antibiotic resistance. This compound's unique properties make it an important subject of investigation for microbiologists and pharmacologists alike, emphasizing its relevance in the ongoing battle against antibiotic-resistant pathogens.</p>

<p>Kanamycin sulfate is a water-soluble antibiotic. Genes encoding kanamycin resistance are commonly used as selection markers in molecular biology .It acts during the translation mechanism in prokaryotic ribosomes to avoid bacterial cell growth.</p>

<p>Potassium clavulanate is a beta-lactamase inhibitor and an antibacterial agent. The presence of potassium clavulanate in culture media inhibits the activity of beta-lactamases, which are enzymes that confer resistance to penicillin and other beta-lactam antibiotics. It also has been shown to be active against bacterial infections such as tuberculosis, sepsis, and pneumonia, where it can inhibit the growth of bacteria by interfering with their ability to form cell walls. Potassium clavulanate is also used as an antimicrobial agent for blood culture technique and antimicrobial treatment.</p>

<p>Ticarcillin disodium salt is a beta-lactam antibiotic that has in vitro activity against Gram-positive and Gram-negative bacteria. Ticarcillin is active against penicillinase-producing strains of Staphylococcus aureus, Enterobacter aerogenes, Proteus mirabilis, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Serratia marcescens, Streptococcus pyogenes, Streptococcus faecalis, and Streptococcus pneumoniae. Furthermore, it inhibits transpeptidase activity of the cell wall of bacteria which prevents peptidoglycan synthesis. It is bactericidal for many bacteria at low concentrations.</p>

<p>Membrane pore-forming agent; H+, K+, Pb2+ ionophore; polyether antibiotic</p>

<p>Aminosidine is a nucleoside analogue that inhibits the HIV-1 reverse transcriptase and the integrase, which are enzymes involved in viral DNA synthesis. Aminosidine is active against Leishmania spp., but not against bacteria. Aminosidine has been shown to be effective in experimental models of human bowel disease and in patients with inflammatory bowel disease. It was also found to be active against wild-type strains of human immunodeficiency virus type 1, but not resistant mutants. The mechanism of action is the inhibition of cellular mitochondrial membrane potential.</p>

<p>Erythromycin derivative</p>

<p>3'-N,N-Di(desmethyl)-3'-N-formyl azithromycin is a semisynthetic macrolide antibiotic derivative, which is synthesized through chemical modification of azithromycin. Azithromycin is originally derived from erythromycin, which is produced by the bacterium Saccharopolyspora erythraea. The modifications in this derivative result in enhanced specificity and altered pharmacokinetic properties compared to the parent compound.</p>

PKUMDL-LTQ-301 is a potent inhibitor of HipA toxin. PKUMDL-LTQ-301 also inhibits E. coli persistence.

<p>DprE1-IN-8 is a potent inhibitor of DprE1, exhibiting an IC50 of less than 0.75 μM.</p>